About this Journal Submit a Manuscript Table of Contents
Enzyme Research
Volume 2011 (2011), Article ID 537821, 7 pages
http://dx.doi.org/10.4061/2011/537821
Review Article

Protein Kinase C and Toll-Like Receptor Signaling

1Center for Cardiovascular Sciences, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA
2Center for Cell Biology and Cancer Research, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA

Received 2 March 2011; Accepted 31 May 2011

Academic Editor: Hong-Jian Zhu

Copyright © 2011 Daniel J. Loegering and Michelle R. Lennartz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Newton, “Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm,” Biochemical Journal, vol. 370, no. 2, pp. 361–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. A. S. Ali, S. Ali, B. F. El-Rayes, P. A. Philip, and F. H. Sarkar, “Exploitation of protein kinase C: a useful target for cancer therapy,” Cancer Treatment Reviews, vol. 35, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Palaniyandi, L. Sun, J. C. Ferreira, and D. Mochly-Rosen, “Protein kinase C in heart failure: a therapeutic target?” Cardiovascular Research, vol. 82, no. 2, pp. 229–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Gonelli, C. Mischiati, R. Guerrini, R. Voltan, S. Salvadori, and G. Zauli, “Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 4, pp. 498–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. S. Bynagari-Settipalli, R. Chari, L. Kilpatrick, and S. P. Kunapuli, “Protein kinase C—possible therapeutic target to treat cardiovascular diseases,” Cardiovascular & Hematological Disorders—Drug Targets, vol. 10, no. 4, pp. 292–308, 2010.
  6. E. Churchill, G. Budas, A. Vallentin, T. Koyanagi, and D. Mochly-Rosen, “PKC isozymes in chronic cardiac disease: possible therapeutic targets?” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 569–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. J. Gay and M. Gangloff, “Structure and function of Toll receptors and their ligands,” Annual Review of Biochemistry, vol. 76, pp. 141–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kawai and S. Akira, “Signaling to NF-kappaB by Toll-like receptors,” Trends in Molecular Medicine, vol. 13, no. 11, pp. 460–469, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Fronhofer, M. R. Lennartz, and D. J. Loegering, “Role of PKC isoforms in the Fc(gamma)R-mediated inhibition of LPS-stimulated IL-12 secretion by macrophages,” Journal of Leukocyte Biology, vol. 79, no. 2, pp. 408–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. F. McGettrick, E. K. Brint, E. M. Palsson-McDermott et al., “Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9196–9201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Kontny, M. Kurowska, K. Szczepanska, and W. Maslinski, “Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes,” Journal of Leukocyte Biology, vol. 67, no. 2, pp. 249–258, 2000. View at Scopus
  13. X. Zhou, W. Yang, and J. Li, “Ca2+- and protein kinase C-dependent signaling pathway for nuclear factor-kappaB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages,” The Journal of Biological Chemistry, vol. 281, no. 42, pp. 31337–31347, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Asehnoune, D. Strassheim, S. Mitra, K. J. Yeol, and E. Abraham, “Involvement of PKCalpha/beta in TLR4 and TLR2 dependent activation of NF-kappaB,” Cellular Signalling, vol. 17, no. 3, pp. 385–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. West, T. Lemieur, L. Clair, J. Bellingham, and J. L. Rodriguez, “Protein kinase C regulates macrophage tumor necrosis factor secretion: direct protein kinase C activation restores tumor necrosis factor production in endotoxin tolerance,” Surgery, vol. 122, no. 2, pp. 204–212, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. M. O. Labeta, J. J. Durieux, G. Spagnoli, N. Fernandez, J. Wijdenes, and R. Herrmann, “CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis,” Immunology, vol. 80, no. 3, pp. 415–423, 1993. View at Scopus
  17. J. Cuschieri, J. Billigren, and R. V. Maier, “Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation,” Journal of Leukocyte Biology, vol. 80, no. 6, pp. 1289–1297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. von Knethen, M. Soller, N. Tzieply, et al., “PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages,” The Journal of Cell Biology, vol. 176, no. 5, pp. 681–694, 2007.
  19. A. D. Foey and F. M. Brennan, “Conventional protein kinase C and atypical protein kinase Czeta differentially regulate macrophage production of tumour necrosis factor-alpha and interleukin-10,” Immunology, vol. 112, no. 1, pp. 44–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. C. Catley, L. M. Cambridge, Y. Nasuhara et al., “Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding,” The Journal of Biological Chemistry, vol. 279, no. 18, pp. 18457–18466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Foreback, V. Sarma, N. R. Yeager, E. M. Younkin, D. G. Remick, and P. A. Ward, “Blood mononuclear cell production of TNF-alpha and IL-8: engagement of different signal transduction pathways including the p42 MAP kinase pathway,” Journal of Leukocyte Biology, vol. 64, no. 1, pp. 124–133, 1998. View at Scopus
  22. D. J. Loegering and M. R. Lennartz, “Signaling pathways for Fc gamma receptor-stimulated tumor necrosis factor-alpha secretion and respiratory burst in RAW 264.7 macrophages,” Inflammation, vol. 28, no. 1, pp. 23–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. St Denis, F. Chano, P. Tremblay, Y. St Pierre, and A. Descoteaux, “Protein kinase C-alpha modulates lipopolysaccharide-induced functions in a murine macrophage cell line,” The Journal of Biological Chemistry, vol. 273, no. 49, pp. 32787–32792, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Chano and A. Descoteaux, “Modulation of lipopolysaccharide-induced NF-IL6 activation by protein kinase C-alpha in a mouse macrophage cell line,” The European Journal of Immunology, vol. 32, no. 10, pp. 2897–2904, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. St Denis, V. Caouras, F. Gervais, and A. Descoteaux, “Role of protein kinase C-alpha in the control of infection by intracellular pathogens in macrophages,” Journal of Immunology, vol. 163, no. 10, pp. 5505–5511, 1999. View at Scopus
  26. A. Breton and A. Descoteaux, “Protein kinase C-alpha participates in FcgammaR-mediated phagocytosis in macrophages,” Biochemical and Biophysical Research Communications, vol. 276, no. 2, pp. 472–476, 2000.
  27. J. D. Ng Yan Hing, M. Desjardins, and A. Descoteaux, “Proteomic analysis reveals a role for protein kinase C-alpha in phagosome maturation,” Biochemical and Biophysical Research Communications, vol. 319, no. 3, pp. 810–816, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Holm, K. Tejle, T. Gunnarsson, K. E. Magnusson, A. Descoteaux, and B. Rasmusson, “Role of protein kinase C alpha for uptake of unopsonized prey and phagosomal maturation in macrophages,” Biochemical and Biophysical Research Communications, vol. 302, no. 4, pp. 653–658, 2003.
  29. C. Langlet, C. Springael, J. Johnson et al., “PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells,” The European Journal of Immunology, vol. 40, no. 2, pp. 505–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Johnson, V. Albarani, M. Nguyen, M. Goldman, F. Willems, and E. Aksoy, “Protein kinase Calpha is involved in interferon regulatory factor 3 activation and type I interferon-beta synthesis,” The Journal of Biological Chemistry, vol. 282, no. 20, pp. 15022–15032, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. K. H. Bhatt, R. K. Pandey, Y. Dahiya, and A. Sodhi, “Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro,” Molecular Immunology, vol. 47, no. 4, pp. 861–870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. C. Kim, S. H. Kim, M. W. Jeong, N. I. Baek, and K. T. Kim, “Effect of rottlerin, a PKC-delta inhibitor, on TLR-4-dependent activation of murine microglia,” Biochemical and Biophysical Research Communications, vol. 337, no. 1, pp. 110–115, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Ikewaki, N. Fujii, T. Onaka, S. Ikewaki, and H. Inoko, “Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement,” Microbiology and Immunology, vol. 51, no. 9, pp. 861–873, 2007.
  34. M. Platten, K. Eitel, J. Wischhusen, J. Dichgans, and M. Weller, “Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast),” Biochemical Pharmacology, vol. 66, no. 7, pp. 1263–1270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Kubo-Murai, K. Hazeki, N. Sukenobu et al., “Protein kinase Cdelta binds TIRAP/Mal to participate in TLR signaling,” Molecular Immunology, vol. 44, no. 9, pp. 2257–2264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. L. E. Kilpatrick, S. W. Standage, H. Li, et al., “Protection against sepsis-induced lung injury by selective inhibition of protein kinase C-{delta} ({delta}-PKC),” Journal of Leukocyte Biology, vol. 89, no. 1, pp. 3–10, 2011.
  37. P. Puneet, C. T. Yap, L. Wong et al., “SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis,” Science, vol. 328, no. 5983, pp. 1290–1294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. L. E. Kilpatrick, J. Y. Lee, K. M. Haines, D. E. Campbell, K. E. Sullivan, and H. M. Korchak, “A role for PKC-delta and PI 3-kinase in TNF-alpha-mediated antiapoptotic signaling in the human neutrophil,” The American Journal of Physiology—Cell Physiology, vol. 283, no. 1, pp. C48–C57, 2002. View at Scopus
  39. R. Cummings, Y. Zhao, D. Jacoby et al., “Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells,” The Journal of Biological Chemistry, vol. 279, no. 39, pp. 41085–41094, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Shukla, K. M. Lounsbury, T. F. Barrett et al., “Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice,” The American Journal of Pathology, vol. 170, no. 1, pp. 140–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Nayak, Y. Huo, W. X. Kwang et al., “Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia,” Neuroscience, vol. 166, no. 1, pp. 132–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Di, T. Kawamura, X. P. Gao et al., “A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury,” The Journal of Biological Chemistry, vol. 285, no. 21, pp. 15848–15857, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. A. Hannun and L. M. Obeid, “Principles of bioactive lipid signalling: lessons from sphingolipids,” Nature Reviews Molecular Cell Biology, vol. 9, no. 2, pp. 139–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. J. Snider, K. A. Orr Gandy, and L. M. Obeid, “Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation,” Biochimie, vol. 92, no. 6, pp. 707–715, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. G. Lu, H. Liu, T. Yamaguchi, Y. Miki, and K. Yoshida, “Protein kinase Cδ activates RelA/p65 and nuclear factor-κB signaling in response to tumor necrosis factor-alpha,” Cancer Research, vol. 69, no. 14, pp. 5927–5935, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. W. H. Chou and R. O. Messing, “Protein kinase C isozymes in stroke,” Trends in Cardiovascular Medicine, vol. 15, no. 2, pp. 47–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. J. H. Kim, J. H. Kim, H. O. Jun, Y. S. Yu, and K. W. Kim, “Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy,” The American Journal of Pathology, vol. 176, no. 3, pp. 1517–1524, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. A. Buder-Hoffmann, A. Shukla, T. F. Barrett, M. B. MacPherson, K. M. Lounsbury, and B. T. Mossman, “A protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos,” The American Journal of Pathology, vol. 174, no. 2, pp. 449–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Castrillo, D. J. Pennington, F. Otto, P. J. Parker, M. J. Owen, and L. Boscá, “Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection,” Journal of Experimental Medicine, vol. 194, no. 9, pp. 1231–1242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Aksoy, Z. Amraoui, S. Goriely, M. Goldman, and F. Willems, “Critical role of protein kinase C epsilon for lipopolysaccharide-induced IL-12 synthesis in monocyte-derived dendritic cells,” The European Journal of Immunology, vol. 32, no. 11, pp. 3040–3049, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Comalada, J. Xaus, A. F. Valledor, C. Lopez-Lopez, D. J. Pennington, and A. Celada, “PKC epsilon is involved in JNK activation that mediates LPS-induced TNF-alpha, which induces apoptosis in macrophages,” The American Journal of Physiology—Cell Physiology, vol. 285, no. 5, pp. C1235–C1245, 2003.
  52. T. Koyanagi, K. Noguchi, A. Ootani, K. Inagaki, R. C. Robbins, and D. Mochly-Rosen, “Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model,” Journal of Molecular and Cellular Cardiology, vol. 43, no. 4, pp. 517–522, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. E. Aksoy, M. Goldman, and F. Willems, “Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders,” The International Journal of Biochemistry and Cell Biology, vol. 36, no. 2, pp. 183–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. S. L. Tan and P. J. Parker, “Emerging and diverse roles of protein kinase C in immune cell signalling,” Biochemical Journal, vol. 376, no. 3, pp. 545–552, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Faisal, A. Saurin, B. Gregory, B. Foxwell, and P. J. Parker, “The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors,” The Journal of Biological Chemistry, vol. 283, no. 27, pp. 18591–18600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. T. Saurin, J. Durgan, A. J. Cameron, A. Faisal, M. S. Marber, and P. J. Parker, “The regulated assembly of a PKCepsilon complex controls the completion of cytokinesis,” Nature Cell Biology, vol. 10, no. 8, pp. 891–901, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Durgan, A. J. Cameron, A. T. Saurin et al., “The identification and characterization of novel PKCepsilon phosphorylation sites provide evidence for functional cross-talk within the PKC superfamily,” Biochemical Journal, vol. 411, no. 2, pp. 319–331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Hirai and K. Chida, “Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions,” The Journal of Biochemistry, vol. 133, no. 1, pp. 1–7, 2003.
  59. A. Duran, M. T. Diaz-Meco, and J. Moscat, “Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation,” The EMBO Journal, vol. 22, no. 15, pp. 3910–3918, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Leitges, L. Sanz, P. Martin et al., “Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway,” Molecular Cell, vol. 8, no. 4, pp. 771–780, 2001. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Hu, R. Jacinto, C. McCall, and L. Li, “Regulation of IL-1 receptor-associated kinases by lipopolysaccharide,” Journal of Immunology, vol. 168, no. 8, pp. 3910–3914, 2002. View at Scopus
  62. X. Huang, L. Y. Chen, A. M. Doerner et al., “An atypical protein kinase C (PKC zeta) plays a critical role in lipopolysaccharide-activated NF-kappa B in human peripheral blood monocytes and macrophages,” Journal of Immunology, vol. 182, no. 9, pp. 5810–5815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Teusch, E. Lombardo, J. Eddleston, and U. G. Knaus, “The low molecular weight GTPase RhoA and atypical protein kinase Czeta are required for TLR2-mediated gene transcription,” Journal of Immunology, vol. 173, no. 1, pp. 507–514, 2004. View at Scopus
  64. C. S. Yang, J. S. Lee, C. H. Song et al., “Protein kinase C zeta plays an essential role for Mycobacterium tuberculosis-induced extracellular signal-regulated kinase 1/2 activation in monocytes/macrophages via Toll-like receptor 2,” Cellular Microbiology, vol. 9, no. 2, pp. 382–396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. Q. Chen, S. Gupta, and A. B. Pernis, “Regulation of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho GTPases,” Journal of Leukocyte Biology, vol. 85, no. 3, pp. 539–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Y. Chen, B. L. Zuraw, F. T. Liu, S. Huang, and Z. K. Pan, “IL-1 receptor-associated kinase and low molecular weight GTPase RhoA signal molecules are required for bacterial lipopolysaccharide-induced cytokine gene transcription,” Journal of Immunology, vol. 169, no. 7, pp. 3934–3939, 2002. View at Scopus
  67. O. Shibolet, C. Giallourakis, I. Rosenberg, T. Mueller, R. J. Xavier, and D. K. Podolsky, “AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling,” The Journal of Biological Chemistry, vol. 282, no. 48, pp. 35308–35317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Manukyan, P. Nalbant, S. Luxen, K. M. Hahn, and U. G. Knaus, “RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via Src to NF-kappa B,” Journal of Immunology, vol. 182, no. 6, pp. 3522–3529, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. H. Lin, Y. Xiao, G. Chen et al., “HMG-CoA reductase inhibitor simvastatin suppresses Toll-like receptor 2 ligand-induced activation of nuclear factor kappa B by preventing RhoA activation in monocytes from rheumatoid arthritis patients,” Rheumatology International, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Yao, J. W. Hwang, J. Moscat et al., “Protein kinase Czeta mediates cigarette smoke/aldehyde- and lipopolysaccharide-induced lung inflammation and histone modifications,” The Journal of Biological Chemistry, vol. 285, no. 8, pp. 5405–5416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. G. L. Sorensen, S. Husby, and U. Holmskov, “Surfactant protein A and surfactant protein D variation in pulmonary disease,” Immunobiology, vol. 212, no. 4-5, pp. 381–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Moulakakis, S. Adam, U. Seitzer, A. B. Schromm, M. Leitges, and C. Stamme, “Surfactant protein A activation of atypical protein kinase C zeta in IkappaB-alpha-dependent anti-inflammatory immune regulation,” Journal of Immunology, vol. 179, no. 7, pp. 4480–4491, 2007. View at Scopus
  73. P. Geraldes and G. L. King, “Activation of protein kinase C isoforms and its impact on diabetic complications,” Circulation Research, vol. 106, no. 8, pp. 1319–1331, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Sommerer and M. Zeier, “AEB071—a promising immunosuppressive agent,” Clinical Transplantation, vol. 23, supplement 21, pp. 15–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Roffey, C. Rosse, M. Linch, A. Hibbert, N. Q. McDonald, and P. J. Parker, “Protein kinase C intervention: the state of play,” Current Opinion in Cell Biology, vol. 21, no. 2, pp. 268–279, 2009. View at Publisher · View at Google Scholar · View at Scopus